HRT FINANCIAL LP purchased $111K of SHPH
HRT FINANCIAL LP purchased 32,591 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.40 ($3.23–$3.44, $0.11M total) across 2 trades over 2026-06-29 to 2026-06-30.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market purchase size, price range, and post-transaction holdings by a 10% owner; it may modestly influence sentiment but does not change company fundamentals in the text.
Market read
Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a durable repricing without accompanying company-specific catalysts.
What to watch
The filing notes no pre-arranged 10b5-1 plan, but it still doesn’t reveal intent, timing constraints, or whether the buy is part of a broader accumulation program.
Background
This is an SEC Form 4 insider transaction disclosure for Shuttle Pharmaceuticals Holdings, Inc.
Ticker impact
HRT Financial LP, a 10% owner, filed a Form 4 showing an open-market purchase of 32,591 SHPH shares at ~$3.40.
Likely limited near-term impact; any effect would be sentiment-driven and small versus broader fundamentals.
Form 4 insider buys can support sentiment, yet the article provides no new operational or financial information beyond the transaction details.
Market effects
No sector-level read-across; this is a single-company ownership transaction.
None indicated.
None indicated.
Counterpoint
A 10% owner buy can reflect liquidity management or diversification rather than a bullish view on near-term fundamentals.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4 insider transaction disclosure.
- 10% ownerHRT Financial LP
Reported open-market purchase of SHPH shares across two trades in late June 2026.